Salidroside-pretreated Mesenchymal Stem Cells Contribute to Neuroprotection in Cerebral Ischemic Injury in Vitro and in Vivo

Overview

Journal J Mol Histol

Specialty Biochemistry

Date 2021 Sep 27

PMID 34570327

Citations 2

Authors

Liping Zhou

Panpan Yao

Lixia Jiang

Zhaoyun Wang

Xiaohe Ma

Guangxin Wen

Jintao Yang

Binjie Zhou

Qin Yu

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs) are considered a promising tool for treating cerebral ischemic injury. However, their poor survival after transplantation limits their therapeutic effect and applications. Salidroside has been reported to exert potent cytoprotective and neuroprotective effects. This study aimed to investigate whether salidroside could improve MSC survival under hypoxic-ischemic conditions and, subsequently, alleviate cerebral ischemic injury in a rat model. MSCs were pretreated by salidroside under hypoxic-ischemic conditions. The cell proliferation, migratory capacity, and apoptosis were evaluated by means of Cell Counting Kit-8, transwell assay, and flow cytometry. MSCs pretreated with salidroside were transplanted into the rats subsequent to middle cerebral artery occlusion. The grip strength, 2,3,5-triphenyltetrazolium chloride, and hematoxylin-eosin staining were used to analyze the therapeutic efficiency and pathological changes. The mature neuron marker NeuN and astrocyte marker GFAP in the focal area were detected by immunofluorescence. These results indicated that salidroside promoted the proliferation, migration and reduced apoptosis of MSCs under hypoxic-ischemic conditions. In vivo experiments revealed that transplantation of salidroside-pretreated MSCs strengthened the therapeutic efficiency by enhancing neurogenesis and inhibiting neuroinflammation in the hippocampal CA1 area after ischemia. Our results suggest that pretreatment with salidroside could be an effective strategy to enhance the cell survival rate and the therapeutic effect of MSCs in treating cerebral ischemic injury.

Citing Articles

Mesenchymal stem cells enchanced by salidroside to inhibit ferroptosis and improve premature ovarian insufficiency via Keap1/Nrf2/GPX4 signaling.

Chen L, Wu Y, Lv T, Tuo R, Xiao Y Redox Rep. 2025; 30(1):2455914.

PMID: 39874130 PMC: 11776066. DOI: 10.1080/13510002.2025.2455914.

Salidroside promotes pro-angiogenesis and repair of blood brain barrier via Notch/ITGB1 signal path in CSVD Model.

Zhilan T, Zengyu Z, Pengpeng J, Hualan Y, Chao L, Yan X J Adv Res. 2024; 68:429-444.

PMID: 38417575 PMC: 11785571. DOI: 10.1016/j.jare.2024.02.019.

Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers.

Malik M, Tlustos P Plants (Basel). 2023; 12(6).

PMID: 36987052 PMC: 10056569. DOI: 10.3390/plants12061364.

Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools.

Kholodenko I, Kholodenko R, Majouga A, Yarygin K Curr Issues Mol Biol. 2022; 44(11):5153-5172.

PMID: 36354663 PMC: 9688732. DOI: 10.3390/cimb44110351.

References

Bai H, Wang C, Ma X, Wei Y, Xi R, Zhao Q . [Effects of salidroside on proliferation of bone marrow mesenchymal stem cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014; 22(4):1072-7. DOI: 10.7534/j.issn.1009-2137.2014.04.035. View

Chen T, Ma Z, Zhu L, Jiang W, Wei T, Zhou R . Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia. Mol Neurobiol. 2015; 53(9):6240-6250. DOI: 10.1007/s12035-015-9521-7. View

Chen J, Liu J, Hu F, Bi Y, Li M, Zhao L . Genetic variants on chromosome 9p21 confer risks of cerebral infarction in the Chinese population: a meta-analysis. Int J Immunopathol Pharmacol. 2019; 33:2058738419847852. PMC: 6503602. DOI: 10.1177/2058738419847852. View

Cunningham C, Redondo-Castro E, Allan S . The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018; 38(8):1276-1292. PMC: 6077926. DOI: 10.1177/0271678X18776802. View

Diaz Lanza A, Abad Martinez M, Fernandez Matellano L, Recuero Carretero C, Villaescusa Castillo L, Silvan Sen A . Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity. Planta Med. 2001; 67(3):219-23. DOI: 10.1055/s-2001-12004. View

Feng G, Zhang J, Li Y, Nie Y, Zhu D, Wang R . IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI. J Am Soc Nephrol. 2016; 27(8):2357-69. PMC: 4978042. DOI: 10.1681/ASN.2015050578. View

Gao J, He H, Jiang W, Chang X, Zhu L, Luo F . Salidroside ameliorates cognitive impairment in a d-galactose-induced rat model of Alzheimer's disease. Behav Brain Res. 2015; 293:27-33. DOI: 10.1016/j.bbr.2015.06.045. View

Ge T, Yu Q, Liu W, Cong L, Liu L, Wang Y . Characterization of bone marrow-derived mesenchymal stem cells from dimethyloxallyl glycine-preconditioned mice: Evaluation of the feasibility of dimethyloxallyl glycine as a mobilization agent. Mol Med Rep. 2016; 13(4):3498-506. PMC: 4805059. DOI: 10.3892/mmr.2016.4945. View

Goldman S . Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking. Cell Stem Cell. 2016; 18(2):174-88. PMC: 5310249. DOI: 10.1016/j.stem.2016.01.012. View

10.

Gui D, Cui Z, Zhang L, Yu C, Yao D, Xu M . Salidroside attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation and apoptosis resistance by upregulating autophagy through the AMPK-mTOR-ULK1 pathway. BMC Pulm Med. 2017; 17(1):191. PMC: 5726034. DOI: 10.1186/s12890-017-0477-4. View

11.

Ha X, Yang B, Hou H, Cai X, Xiong W, Wei X . Protective effect of rhodioloside and bone marrow mesenchymal stem cells infected with HIF-1-expressing adenovirus on acute spinal cord injury. Neural Regen Res. 2019; 15(4):690-696. PMC: 6975151. DOI: 10.4103/1673-5374.266920. View

12.

Han T . Effects of salidroside pretreatment on expression of tumor necrosis factor-alpha and permeability of blood brain barrier in rat model of focal cerebralischemia-reperfusion injury. Asian Pac J Trop Med. 2013; 6(2):156-8. DOI: 10.1016/S1995-7645(13)60014-0. View

13.

Hedhli J, Konopka C, Schuh S, Bouvin H, Cole J, Huntsman H . Multimodal Assessment of Mesenchymal Stem Cell Therapy for Diabetic Vascular Complications. Theranostics. 2017; 7(16):3876-3888. PMC: 5667411. DOI: 10.7150/thno.19547. View

14.

Huang L, Zhang L . Neural stem cell therapies and hypoxic-ischemic brain injury. Prog Neurobiol. 2018; 173:1-17. PMC: 6249121. DOI: 10.1016/j.pneurobio.2018.05.004. View

15.

Jiang J, Dai J, Cui H . Vitexin reverses the autophagy dysfunction to attenuate MCAO-induced cerebral ischemic stroke via mTOR/Ulk1 pathway. Biomed Pharmacother. 2018; 99:583-590. DOI: 10.1016/j.biopha.2018.01.067. View

16.

Ju L, Wen X, Wang C, Wei Y, Peng Y, Ding Y . Salidroside, A Natural Antioxidant, Improves β-Cell Survival and Function via Activating AMPK Pathway. Front Pharmacol. 2017; 8:749. PMC: 5651268. DOI: 10.3389/fphar.2017.00749. View

17.

Laroni A, Novi G, Kerlero de Rosbo N, Uccelli A . Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. J Neuroimmune Pharmacol. 2013; 8(5):1062-76. DOI: 10.1007/s11481-013-9456-6. View

18.

Li F, Zhao S . Mesenchymal stem cells: Potential role in corneal wound repair and transplantation. World J Stem Cells. 2014; 6(3):296-304. PMC: 4131271. DOI: 10.4252/wjsc.v6.i3.296. View

19.

Li Q, Guo Y, Chen F, Liu J, Jin P . Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Exp Ther Med. 2016; 12(1):45-50. PMC: 4906949. DOI: 10.3892/etm.2016.3309. View

20.

Mangin G, Poittevin M, Charriaut-Marlangue C, Giannesini C, Merkoulova-Rainon T, Kubis N . Glatiramer acetate reduces infarct volume in diabetic mice with cerebral ischemia and prevents long-term memory loss. Brain Behav Immun. 2019; 80:315-327. DOI: 10.1016/j.bbi.2019.04.009. View